Cancer immunotherapy breakthrough reactivates tumor suppressor protein

Researchers at Karolinska Institute in Sweden have made a breakthrough in the arms race that is cancer immunotherapy. The team has blocked a protein that silences an important tumor-suppressing protein, allowing the latter to get back to work.Continue … Continue reading Cancer immunotherapy breakthrough reactivates tumor suppressor protein

New mechanism controls superbugs by sparing the death sentence

Antibiotics are reaching the limits of their usefulness, as they drive bacteria to evolve into new drug-resistant forms. But a new study has uncovered a mechanism that could make the bugs non-infectious without killing them, reducing the evolutionary p… Continue reading New mechanism controls superbugs by sparing the death sentence

Personalized therapy for aggressive brain cancer shows promising results

Newly announced results from a preliminary clinical trial testing a novel kind of brain cancer drug have revealed incredibly promising responses in a particular subset of patients. A larger Phase 2 trial is now underway targeting patients with a specif… Continue reading Personalized therapy for aggressive brain cancer shows promising results

Existing drug shows promise targeting common cancer mutation

Difficult to detect and with a low survival rate, pancreatic cancer is one of the most insidious forms of the disease. But now, researchers have identified an existing drug that could be repurposed to fight pancreatic cancer by targeting a key gene mut… Continue reading Existing drug shows promise targeting common cancer mutation

Existing drug shows promise targeting common cancer mutation

Difficult to detect and with a low survival rate, pancreatic cancer is one of the most insidious forms of the disease. But now, researchers have identified an existing drug that could be repurposed to fight pancreatic cancer by targeting a key gene mut… Continue reading Existing drug shows promise targeting common cancer mutation

Novavax COVID-19 vaccine hits 90% efficacy in large US trial

Biotechnology company Novavax has announced the long-awaited results from its large Phase 3 COVID-19 vaccine trial, revealing over 90 percent protection from symptomatic infection and 100 percent protection from moderate to severe disease. The vaccine … Continue reading Novavax COVID-19 vaccine hits 90% efficacy in large US trial

Caloric restriction-mimicking gene extends health and lifespan of mice

It’s inevitable that our health declines as we age, but maybe we can slow down that process. A new study led by Bar-Ilan University has found that boosting a certain gene in mice can increase their lifespan and keep them in better health for longer by … Continue reading Caloric restriction-mimicking gene extends health and lifespan of mice

Scientists discover how stem cells trigger muscle regeneration

Researchers at the Salk Institute have uncovered a mechanism by which stem cells can help regenerate muscles. The discovery could provide a new drug target for repairing muscles after injury or rebuilding muscle mass lost during the normal aging proces… Continue reading Scientists discover how stem cells trigger muscle regeneration

Switching off a stomach protein seems to help regulate obesity in mice

Researchers at Indiana University have linked a protein secreted by the stomach to obesity. In tests in mice, the team switched off the protein and found that it reduced the animals’ body fat levels, even when fed a high-fat diet.Continue ReadingCatego… Continue reading Switching off a stomach protein seems to help regulate obesity in mice

Experimental enzyme inhibitor could herald new class of cancer drug

Scientists at Cambridge have demonstrated a new method for potentially fighting a form of leukemia, by targeting overactive enzymes that can lead to the disease. If the results of mice tests carry across to humans, it could be the first of a new class … Continue reading Experimental enzyme inhibitor could herald new class of cancer drug